AIDSinfo Releases Fact Sheet on Dovato, a New HIV Medication

AIDSinfo Releases Fact Sheet on Dovato, a New HIV Medication

The Food and Drug Administration (FDA) recently approved Dovato, a new antiretroviral medication to treat HIV infection. The two-drug (dolutegravir and lamivudine), fixed-dose combination tablet is approved to treat HIV infection in adults who meet certain requirements, as determined by a health care provider. Dovato is a complete regimen for the treatment of HIV infection and should not be used with other HIV medicines. To learn more about Dovato, please see the AIDSinfo Dovato fact sheet [en español]. 

Do you want to learn more about HIV medicines? Check out the AIDSinfo FDA-Approved HIV Medicines fact sheet and infographic.

AIDSinfo Highlights Two HIV/AIDS Awareness Days in May

Learn about two HIV/AIDS awareness days observed in May: 

May 18: HIV Vaccine Awareness Day 

HIV Vaccine Awareness Day is an occasion to highlight HIV vaccine research and to recognize the many volunteers, community members, health professionals, and scientists involved in this important research. To learn more, visit the AIDSinfo HIV Vaccine Awareness Day webpage [en español]. 

May 19: National Asian & Pacific Islander HIV/AIDS Awareness Day 

The focus of National Asian & Pacific Islander HIV/AIDS Awareness Day is to break the silence about HIV and AIDS in Asian and Pacific Islander communities in the United States and to encourage community members to get tested for HIV. To learn more, browse the AIDSinfo National Asian & Pacific Islander HIV/AIDS Awareness Day webpage [en español].